Effects of Combined Alcohol and Nitrous Oxide Intake - 15

This study has been completed.

First Received: September 20, 1999 Last Updated: August 16, 2005 History of Changes

Sponsor:	National Institute on Drug Abuse (NIDA)
Collaborator:	University of Chicago
Information provided by:	National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:	NCT00000263

Purpose

The purpose of this study is to determine the effects of combined alcohol and nitrous oxide intake on mood, psychomotor performance, and the pain response in healthy volunteers.

Condition	Intervention	Phase
Opioid-Related Disorders Substance-Related Disorders	Drug: Nitrous oxide	Phase II

Study Type:	Interventional
Study Design:	Treatment
Official Title:	Effects of Combined Alcohol and Nitrous Oxide Intake

Resource links provided by NLM:

Drug Information available for: Nitrous oxide

U.S. FDA Resources

Further study details as provided by National Institute on Drug Abuse (NIDA):

Primary Outcome Measures:

Pain intensity, pain bothersomeness
Mood
Psychomotor performance
Cognitive performance

Estimated Enrollment:	0
Study Start Date:	January 1997

Eligibility

Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Please contact site for information.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00000263

Locations

United States, Illinois
University of Chicago, Anesthesia & Critical Care
Chicago, Illinois, United States, 60637

Sponsors and Collaborators

National Institute on Drug Abuse (NIDA)

University of Chicago

Investigators

Principal Investigator:

James Zacny, Ph.D.

University of Chicago

More Information

No publications provided

Study ID Numbers:	NIDA-08391-15, R01-08391-15
Study First Received:	September 20, 1999
Last Updated:	August 16, 2005
ClinicalTrials.gov Identifier:	NCT00000263 History of Changes
Health Authority:	United States: Federal Government

Additional relevant MeSH terms:

Disease
Nitrous Oxide
Physiological Effects of Drugs
Central Nervous System Depressants
Anesthetics
Disorders of Environmental Origin
Opioid-Related Disorders
Pharmacologic Actions
Anesthetics, Inhalation
Pathologic Processes

Anesthetics, General
Mental Disorders
Analgesics, Non-Narcotic
Sensory System Agents
Therapeutic Uses
Substance-Related Disorders
Analgesics
Peripheral Nervous System Agents
Central Nervous System Agents

ClinicalTrials.gov processed this record on November 27, 2009